KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Invested Capital (2016 - 2025)

Historic Invested Capital for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $534.1 million.

  • Dynavax Technologies' Invested Capital fell 2161.48% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 2161.48%. This contributed to the annual value of $596.8 million for FY2024, which is 406.27% down from last year.
  • Latest data reveals that Dynavax Technologies reported Invested Capital of $534.1 million as of Q3 2025, which was down 2161.48% from $494.2 million recorded in Q2 2025.
  • Dynavax Technologies' Invested Capital's 5-year high stood at $681.4 million during Q3 2024, with a 5-year trough of $67.6 million in Q3 2021.
  • Moreover, its 5-year median value for Invested Capital was $534.1 million (2025), whereas its average is $459.6 million.
  • As far as peak fluctuations go, Dynavax Technologies' Invested Capital surged by 74372.46% in 2021, and later tumbled by 2312.94% in 2025.
  • Dynavax Technologies' Invested Capital (Quarter) stood at $222.4 million in 2021, then skyrocketed by 161.28% to $581.0 million in 2022, then rose by 7.07% to $622.1 million in 2023, then dropped by 4.06% to $596.8 million in 2024, then fell by 10.5% to $534.1 million in 2025.
  • Its Invested Capital stands at $534.1 million for Q3 2025, versus $494.2 million for Q2 2025 and $530.9 million for Q1 2025.